Adding venetoclax to decitabine-cedazuridine significantly enhanced response rates in patients with higher-risk ...

Brittain G, et al. Real-world effectiveness and predictors of response to autologous hematopoietic stem cell transplantation in MS: The UK experience in 271 patients treated during 2000-2023.

Prime Medicine’s modular editing tech may lower off-target risk, but key data and funding milestones remain ahead. Find out ...

A pair of identical twins only four and a half years old have become China's youngest-ever hematopoietic stem cell donors, ...

The patient ... stem cells by growing them in a lab can treat the cell deficiency that gives rise to corneal blood vessel growth, cloudiness and pain, Jurkunas said. Jurkunas said the transplant ...

The following is a summary of "A study protocol for a double-blinded, randomised, placebo-controlled trial on the use of encapsulated FMT for reducing the side effects of HSCT: the HSCT-BIOME study," ...

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a critical therapeutic strategy for treating conditions such as hematological ...

Researchers sought to determine whether MSD HSCT or auto-HSCT would have advantages over chemotherapy in post-remission treatment for patients with AML.

Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the ...